2-(4-(4-methoxybenzoyl)piperidinylcarbonyl)-4-methylpyridine-5-carboxylic acid

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(4-(4-methoxybenzoyl)piperidinylcarbonyl)-4-methylpyridine-5-carboxylic acid
• 英文别名: 6-[4-(4-Methoxybenzoyl)piperidine-1-carbonyl]-4-methylpyridine-3-carboxylic acid；6-[4-(4-methoxybenzoyl)piperidine-1-carbonyl]-4-methylpyridine-3-carboxylic acid
• 化学式: C₂₁H₂₂N₂O₅
• 分子量: 382.416
• InChiKey: QPOBVSHDHQSZNS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  28
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  96.8
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  sodium chlorite 、 氨基磺酸 以 水 为溶剂， 以85%的产率得到2-(4-(4-methoxybenzoyl)piperidinylcarbonyl)-4-methylpyridine-5-carboxylic acid
  参考文献：
  名称：

  5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them

  摘要：

  本公开涉及特定的羧酰胺、磺酰胺和胺化合物及其药物组合物，以及治疗和改善与脂联素途径、鞘脂代谢、氧化应激、线粒体功能障碍、自由基损伤和代谢低效等相关的疾病和状况的方法。在某些实施例中，这些化合物的结构如（I-1）、（2-I）和（3-I）所示 其中变量如本文所述。

  公开号：

  US09409884B2

文献信息

• Carboxamide, Sulfonamide and Amine Compounds and Methods for Using Them
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US20140378429A1

  公开（公告）日：2014-12-25

  The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) (The chemical formulas should be inserted here) in which the variables are as described herein.

  本公开涉及特定的羧酰胺、磺酰胺和胺化合物及其制药组合物，以及治疗和改善与脂联素途径、鞘脂代谢、氧化应激、线粒体功能障碍、自由基损伤和代谢效率等相关的疾病和病症的方法。在某些实施例中，化合物具有结构（I-1）、（2-I）和（3-I）（化学式应在此处插入），其中变量如本文所述。
• US9409884B2
  申请人：——

  公开号：US9409884B2

  公开（公告）日：2016-08-09
• [EN] CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS AND METHODS FOR USING THEM<br/>[FR] COMPOSÉS DE CARBOXAMIDE, DE SULFONAMIDE ET D'AMINE ET PROCÉDÉS POUR UTILISER CEUX-CI
  申请人：RIGEL PHARMACEUTICALS INC

  公开号：WO2013116491A1

  公开（公告）日：2013-08-08

  The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) (The chemical formulas should be inserted here) in which the variables are as described herein.
• 5- or 6-substituted benzofuran-2-carboxamide compounds and methods for using them
  申请人：Rigel Pharmaceuticals, Inc.

  公开号：US09409884B2

  公开（公告）日：2016-08-09

  The disclosure relates particularly to certain carboxamide, sulfonamide and amine compounds and pharmaceutical compositions thereof, and to methods of treating and ameliorating disorders and conditions related to the adiponectin pathway, sphingolipid metabolism, oxidative stress, mitochondrial dysfunction, free radical damage and metabolic inefficiency, among others. In certain embodiments, the compounds have the structures (I-1), (2-I) and (3-I) in which the variables are as described herein.

  本公开涉及特定的羧酰胺、磺酰胺和胺化合物及其药物组合物，以及治疗和改善与脂联素途径、鞘脂代谢、氧化应激、线粒体功能障碍、自由基损伤和代谢低效等相关的疾病和状况的方法。在某些实施例中，这些化合物的结构如（I-1）、（2-I）和（3-I）所示 其中变量如本文所述。